Stresnil RF 0.5 Tablet (Alprazolam 0.5/Melatonin 3mg)

Stresnil RF 0.5mgTablet is an effective drug prescribed to patients who have trouble sleeping. The drug controls the levels of certain unbalanced chemicals released by the brain in patients who suffer from insomnia. This class of drugs work in a way through which they calm the brain and the central nervous system.

Stresnil RF  medicine also relieves anxiety in patients with by controlling the levels of certain unbalanced chemicals released by the brain in patients who suffer from depression. It helps in regulating the sleep cycle and aids patients to sleep quickly.

Stresnil RF 0.5mg drug can become addictive, thus it should not be used in individuals who have a history of drug addiction. Before you start the medication, research some general information about it. For instance, the drug is not meant for patients who suffer from problems like glaucoma and allergies. Inform your doctor if you have health issues like epileptic seizures and asthma.

The medication can result in birth defects. Therefore it should not be consumed by pregnant women. Traces of the drug has been found in breast milk too and can have a negative impact on the infant. Thus, breastfeeding mothers are also advised not to take it.

Some side effects of the medication include tiredness, feeling sleepy, memory issues and developing anxiousness. Experiencing withdrawal symptoms is also a common side effect of this tablet.

Stresnil RF  medication helps in treating the following problem in the human body:

Insomnia

Dosage

The side effects of this medication are as follows:

Confusion

Drowsiness

Tiredness

Uncoordinated Body Movements

Depression

Memory Impairment

Are there any missed dose instructions?

Missed dose should be taken as soon as possible. It is recommended to skip your missed dose, if it is the time for your next scheduled dose.

Are there any overdose instructions?

Seek emergency medical treatment or contact the doctor in case of an overdose.

The medication has a high affinity for the benzodiazepine binding site in the brain. It facilitates the inhibitory neurotransmitter action of gamma-aminobutyric acid, which mediates both pre- and post-synaptic inhibition in the central nervous system (CNS). It also works on adenylate cyclase and the blocking of a cAMP signal transduction pathway, after binding to melatonin receptor type 1A. This drug triggers phospholipase C.